BD Completes $275M Acquisition of HandyLab

BD paid $275 million for the privately held molecular diagnostics firm. It will integrate its GeneOhm assays with a new platform based on HandyLab's instrument.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories